Browsing by Author Shao, Zonghong

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 8 of 8
Issue Date Title Author(s)
2016 Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China Lu, Jin;Hou, Jian;Liu, Kai-Yan;Parmar, Simrit;De La Fuente, Adolfo;Andersson, Borje;Yan, ChenHua;Zhou, Daobin;Tan, Daryl;Ritchie, David;Wu, Deipei;Shpall, Elizabeth;Laport, Ginna G.;Li, JianYong;Hu, Jiong;Zhang, Lian Sheng;Wang, Michael;Malhotra, Pankaj;Jiang, Qian;Qin, Yazhen;Wong, Raymond;Champlin, Richard;Issaragrisil, Surapol;Iyer, Swaminathan;Mathews, Vikram;Wang, Yu;Hu, Yu;Xiao, Zhijian;Shao, Zonghong;Rosengarten, Rafael;Steuernagle, Jon;Xiao, Jun Huang;Orlowski, Robert;Chim, Chor Sang
2017 Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China Zhang, Xiaohui;Hu, Jiong;Hu, Yu;Huang, He;Jin, Jie;Li, Juan;Liu, Qifa;Shao, Zonghong;Wang, Jianxiang;Wang, Quanshun;Wu, Depei;Huang, Xiaojun
2014 The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China Wang, Huaquan;Tu, Meifeng;Fu, Rong;Wu, Yuhong;Liu, Hong;Xing, Limin;Shao, Zonghong
2015 Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study Wu, Depei;Du, Xin;Jin, Jie;Xiao, Zhijian;Shen, Zhixiang;Shao, Zonghong;Li, Xiao;Huang, Xiaojun;Liu, Ting;Yu, Li;Li, Jianyong;Chen, Baoan;He, Guangsheng;Cai, Zhen;Liang, Hongchuang;Li, Jigang;Ruan, Changgeng
2018 Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China Zhang, Xiaohui;Hu, Jiong;Hu, Yu;Huang, He;Jin, Jie;Li, Juan;Liu, Qifa;Shao, Zonghong;Wang, Jianxiang;Wang, Quanshun;Wu, Depei;Huang, Xiaojun
2018 FINAL Results of an Phase, Multicenter, Randomied, Controlled OPEN LEVEL Trial: Decitabine Therapy in Patients with Myelodysplastic Syndromes Shao, Zonghong;Liu, Hui;Jiang, Hao;Tong, Hongyan;Xiang, Ruixiang;Yang, Linhua;Zhao, Hongguo;Ouyang, Jian;Bai, Hai;Sun, Hui;Hou, Li;Jiang, Ming;Yun, Zeng;Liu, Zhuogang;Liang, Aibin;Xie, Yinghua;Yu, Kang;Zhai, Zhimin;Liu, Li
2017 Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China Huang, Xiao Jun;Liu, Kaiyan;Ritchie, David;Andersson, Borje;Lu, Jin;Hou, Jian;Burguera, Adolfo de la Fuente;Wang, JianXiang;Yeoh, Allen;Yan, Chenhua;Zhou, Daobin;Tan, Daryl;Kim, Dong Wook;Wu, Depei;Shpall, Elizabeth;Kornblau, Stephen;Neelapu, Sattava;Hongeng, Suradej;Li, Jianyong;Hu, Jiong;Zhang, Lian Sheng;Wang, Michael;Malhotra, Pankaj;Jiang, Qian;Qin, Yazhen;Wong, Raymond;Champlin, Richard;Hagemeister, Frederick;Westin, Jason;Iyer, Swaminathan;Mathews, Vikram;Wang, Yu;Hu, Yu;Xiao, Zhijian;Shao, Zonghong
Mar-2021 Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment Liu, Yumei;Yang, Chen;Xue, Hua;Ye, Fang;Sun, Wanling;Wang, Jingbo;Qi, Weiwei;Niu, Haiyue;Hua, Luoming;Wang, Huaquan;Han, Bing;Shao, Zonghong